Similar rates of survival without severe morbidity versus placebo in PDA trial ...

Neoadjuvant HPV16-specific arenavirus-based immunotherapy HB-200 plus chemotherapy followed by response-stratified de-intensification in HPV16+ oropharyngeal cancer: TARGET-HPV. This is an ASCO ...

– Announcement follows recent U.S. government award from the Biomedical Advanced Research and Development Authority supporting development of VIR-2482 – SAN FRANCISCO, Oct. 18, 2022 (GLOBE NEWSWIRE) - ...

Current guidelines recommend 5 to 7 days of broad-spectrum antibiotic prophylaxis for upper gastrointestinal bleeding in patients with cirrhosis. In a systematic review and meta-analysis, shorter ...

US Food and Drug Administration Approval Summary: Ribociclib With an Aromatase Inhibitor in the Adjuvant Hormone Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Stage II and III ...

We conducted a phase 2–3 double-blind trial to assess the efficacy and safety of nirmatrelvir–ritonavir in asymptomatic, rapid antigen test–negative adults who had been exposed to a household contact ...